PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis

First Page		Document Content
Date: 2013-09-17 12:37:08 Immunology Biology Alemtuzumab Genzyme Sanofi Interferon beta-1a CD52 Interferon Therapies under investigation for multiple sclerosis Multiple sclerosis Cytokines Immune system		PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis Add to Reading List Source URL: en.sanofi.com Download Document from Source Website File Size: 83,00 KB Share Document on Facebook

	Requesting Retirement of a Vehicle Agreement Asset through the CD52 Form (NOAA only) The purpose of this document is to outline the steps for creating a request for retirement of a Vehicle Agreement Asset through the CD5 DocID: 1pNf6 - View Document
	Certificate The Food Safety Management System of Air Liquide CO2 Europe SA Site Borealis PEC-Rhin SAS Route CD52 DocID: 1n7pj - View Document
	PDF Document DocID: lwGW - View Document
	PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis DocID: 5CpM - View Document
	A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects DocID: 53Gr - View Document